This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. rose 4.9% to $9.23 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 1.2% to 19,529.95 and the Dow Jones Industrial Average rising 1.0% to 42,762.87.
This was the stock's fourth consecutive day of gains.
Corbus Pharmaceuticals Holdings Inc. closed 85.1% short of its 52-week high of $61.90, which the company reached on July 31st.
The stock demonstrated a mixed performance when compared to some of its competitors, as Vanda Pharmaceuticals Inc. rose 5.0% to $4.61, Fortress Biotech Inc. rose 6.4% to $2.00, and Viking Therapeutics Inc. rose 2.92% to $27.83.
Trading volume totaled 151,362, compared to the 50-day average of 153,733.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
June 06, 2025 16:34 ET (20:34 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.